Art

J-GLOBAL ID：202002279978228520   Reference number：20A1762133

Comparable responses of immunological markers in Japanese and European subjects after SQ HDM SLIT-tablet treatment

SQ HDM SLIT錠剤処置後の日本人と欧州人被験者における免疫学的マーカーの同等応答

Author (10)： Ohashi-Doi Katsuyo (Torii Pharmaceuticals Co., Ltd.) ,  Lund Kaare (ALK-Abello A/S) ,  Lund Kaare (Papermill Medical) ,  Ipsen Henrik (ALK-Abello A/S) ,  Andersen Peter Sejr (ALK-Abello A/S) ,  Mosbech Holger (Allergy Clinic, Copenhagen University Hospital) ,  Virchow J. Christian (University of Rostock) ,  Kudo Minoru (Torii Pharmaceuticals Co., Ltd.) ,  Stranzl Thomas (ALK-Abello A/S) ,  Matsuoka Tomokazu (University of Yamanashi)
Material： Allergology International  (Allergol Int)
Volume： 69  Issue： 2  Page： 281-283(J-STAGE)  Publication year： 2020 
JST Material Number： L6446A  ISSN： 1323-8930  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： nasal allergy ,...
Semi thesaurus term： Allergic asthma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1762133&from=J-GLOBAL&jstjournalNo=L6446A") }}

JST classification (1)： Treatment for immunologic diseases,allergic diseases.  (GD04030Y)

Reference (10)：

• 1. Okubo K, Masuyama K, Imai T, Okamiya K, Stage BS, Seitzberg D, et al. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. J Allergy Clin Immunol 2017;139:1840-8.
• 2. Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA 2016;315:1715-25.
• 3. Nolte H, Bernstein DI, Nelson HS, Kleine-Tebbe J, Sussman GL, Seitzberg D, et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2016;138:1631-8.
• 4. Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper. Allergy 2014;69:854-67.
• 5. Shamji MH, Kappen JH, Akdis M, Jensen-Jarolim E, Knol EF, Kleine-Tebbe J, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI position paper. Allergy 2017;72:1156-73.

Terms in the title (10)： HDM ,  錠剤 ,  処置 ,  日本人 ,  欧州 ,  被験者 ,  免疫学 ,  マーカー ,  同等 ,  応答